Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
roche
4
×
san francisco top stories
biotech
blueprint medicines
boston blog main
boston top stories
clinical trials
fda
genentech
san francisco blog main
avapritinib
boston
cancer
eli lilly
europe top stories
indiana blog main
indiana top stories
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
novartis
pralsetinib
selpercatinib
thyroid cancer
billy dunn
biogen
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
companion diagnostic
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
dna sequencing
What
drug
4
×
fda
4
×
cancer
approval
approved
blueprint
genetic
medicine
medicines
new
ret
roche
therapy
address
approves
atrophy
candidate
carries
certain
currently
daily
deeper
designed
dna
evrysdi
fingerprint
friday
going
green
home
intended
latest
lights
liquid
marketing
matter
muscle
muscular
nd
oks
Language
unset
Current search:
roche
×
fda
×
drug
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues